Skip to main content
Log in

LMNA p.Arg624His Variant Reduces Lamin Expression at mRNA Level: Elucidating Molecular Pathways toward Cardiac Involvement in Laminopathies

  • Short Communication
  • Published:
Journal of Cardiovascular Translational Research Aims and scope Submit manuscript

Graphical Abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Data Availability

The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

  1. Hershberger RE, Jordan E. LMNA-Related Dilated Cardiomyopathy. In: Gene Reviews [Internet]. University of Washington, Seattle; 2008 June 12 [updated 2022 March 17]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1674/#top. Accessed 2-9-24. 

  2. Zahr HC, Jaalouk DE. Exploring the Crosstalk Between LMNA and Splicing Machinery Gene Mutations in Dilated Cardiomyopathy. Front Genet. 2018;9. https://doi.org/10.3389/fgene.2018.00231.

  3. Narula N, Favalli V, Tarantino P, Grasso M, Pilotto A, Bellazzi R, et al. Quantitative expression of the mutated lamin A/C gene in patients with cardiolaminopathy. J Am Coll Cardiol. 2012;60:1916–20. https://doi.org/10.1016/j.jacc.2012.05.059.

    Article  CAS  PubMed  Google Scholar 

  4. Kato K, Ohno S, Sonoda K, Fukuyama M, Makiyama T, Ozawa T, et al. LMNA Missense Mutation Causes Nonsense-Mediated mRNA Decay and Severe Dilated Cardiomyopathy. Circ Genom Precis Med. 2020;13:435–43. https://doi.org/10.1161/CIRCGEN.119.002853.

    Article  CAS  PubMed  Google Scholar 

  5. Morales A, Kinnamon DD, Jordan E, Platt J, Vatta M, Dorschner MO, et al. Variant interpretation for dilated cardiomyopathy: refinement of the American College of Medical Genetics and Genomics/ClinGen Guidelines for the DCM Precision Medicine Study. Circulation: Genomic and Precision Medicine. 2020;13(4):e002480. https://doi.org/10.1161/CIRCGEN.119.002480.

Download references

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jose Angel Urbano-Moral.

Ethics declarations

Ethical Approval

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. No animal studies were carried out by the authors for this article.

Consent To Publish

The authors affirm that human research participants provided informed consent for publication of the images in Fig. 1b.

Informed Consent

Informed consent was obtained from all patients for being included in the study.

Conflicts Of Interest

The authors declare that they have no conflict of interest.

Additional information

Associate Editor Paul J. R. Barton oversaw the review of this article

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jimenez-Alcantara, I., Lozano-Velasco, E., Caño-Carrillo, S. et al. LMNA p.Arg624His Variant Reduces Lamin Expression at mRNA Level: Elucidating Molecular Pathways toward Cardiac Involvement in Laminopathies. J. of Cardiovasc. Trans. Res. (2024). https://doi.org/10.1007/s12265-024-10512-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12265-024-10512-y

Keywords

Navigation